Insilico Medicine Collaborates with the Indiana Biosciences Research Institute
Insilico Medicine , a global leader in deep learning for drug discovery and development, is pleased to announce that it has entered into a research collaboration with the Indiana Biosciences...
IBRI IN THE NEWS: BioCrossroads Adds to Board
BioCrossroads has added Adrienne Brown and Alan Palkowitz to its board of directors. Brown serves as vice president of US Diabetes at Eli Lilly and Co. and oversees commercial efforts...
BioCrossroads adds Lilly, Indiana Biosciences Research Institute executives to Board of Directors
Indianapolis, Ind. – BioCrossroads announces that Adrienne Brown, vice president of US Diabetes at Eli Lilly and Company, and Alan Palkowitz, PhD, president and CEO of the Indiana Biosciences Research...
IBRI Receives Greenovation Award from Kimberly-Clark
In 2020, the IBRI diverted more than 370 pounds of waste from landfills, by participating in the RightCycle Program with Kimberly-Clark Professional....
IBRI RESEARCH PUBLISHED: The role of mediobasal hypothalamic PACAP in the control of body weight and metabolism
Abstract Body energy homeostasis results from balancing energy intake and energy expenditure. Central nervous system administration of pituitary adenylate cyclase activating polypeptide (PACAP) dramatically alters metabolic function, but the...
IBRI RESEARCH PUBLISHED: Multiplexed Signal Ion Emission Reactive Release Amplification Assay for the Culture-Free Detection of Gram-Negative, Gram-Positive Bacteria and Antimicrobial Resistance Genes
Abstract The global prevalence of antibiotic-resistant bacteria has increased the risk of dangerous infections, requiring rapid diagnosis and treatment. The standard method for diagnosis of bacterial infections remains dependent...
IBRI RESEARCH PUBLISHED: Endogenous mitochondrial double-stranded RNA is not an activator of the type I interferon response in human pancreatic beta cells
Abstract Background: Type 1 diabetes (T1D) is an autoimmune disease characterized by the progressive destruction of pancreatic beta cells. Interferon-α (IFNα), an antiviral cytokine, is expressed in the pancreatic...
IBRI IN THE NEWS: IBRI's new CEO brings experience from industry, academia
Dr. Alan Palkowitz spent 28 years in industry before becoming an academic research scientist. Those two experiences were perfect preparation for his new role as the leader of an organization...
IBRI RESEARCH PUBLISHED: Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes
Abstract The incidence of obesity and type 2 diabetes (T2D) has been increasing steadily worldwide. It is estimated that by 2045 more than 800 million people will be suffering...
IBRI RESEARCH PUBLISHED: Pro-Inflammatory Cytokines Induce Insulin and Glucagon Double Positive Human Islet Cells That Are Resistant to Apoptosis
Abstract The presence of islet cells double positive for insulin and glucagon (Ins + /Glu + ) has been described in the pancreas from both type 2 (T2D) and...